WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANIP

Based on 5 analysts offering 12 month price targets for Ani Pharmaceuticals Inc

Min Forecast
$90.00+21.56%
Avg Forecast
$110.00+48.57%
Max Forecast
$124.00+67.48%

Should I buy or sell ANIP stock?

Based on 5 analysts offering ratings for Ani Pharmaceuticals Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ANIP stock forecasts and price targets.

ANIP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-16
lockedlocked$00.00+00.00%2025-12-09
lockedlocked$00.00+00.00%2025-10-09
lockedlocked$00.00+00.00%2025-09-24
lockedlocked$00.00+00.00%2025-09-17

1 of 1

Forecast return on equity

Is ANIP forecast to generate an efficient return?

Company
53.67%
Industry
59.54%
Market
181.35%
ANIP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANIP forecast to generate an efficient return on assets?

Company
20.15%
Industry
19.31%
ANIP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANIP earnings per share forecast

What is ANIP's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$9.09+159.83%
Avg 2 year Forecast
$10.82+209.21%
Avg 3 year Forecast
$11.78+236.45%
ANIP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ANIP revenue forecast

What is ANIP's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$1.1B+19.88%
Avg 2 year Forecast
$1.2B+38.79%
Avg 3 year Forecast
$1.3B+46.71%
ANIP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANIP earnings growth forecast

How is ANIP forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
50.56%
Industry
13.49%
Market
36.44%
ANIP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ANIP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ANIP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ANIP revenue growth forecast

How is ANIP forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
14.18%
Industry
7.99%
Market
13.44%
ANIP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANIP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANIP vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ANIP$74.04$110.00+48.57%Strong Buy
PRGO$10.72$19.33+80.35%Buy
PAHC$47.92$50.00+4.34%Strong Buy
HROW$36.35$71.14+95.72%Strong Buy
BHC$5.38$7.50+39.41%Hold
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Forecast FAQ

Is Ani Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ANIP) stock is to Strong Buy ANIP stock.

Out of 5 analysts, 3 (60%) are recommending ANIP as a Strong Buy, 1 (20%) are recommending ANIP as a Buy, 1 (20%) are recommending ANIP as a Hold, 0 (0%) are recommending ANIP as a Sell, and 0 (0%) are recommending ANIP as a Strong Sell.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.

What is ANIP's earnings growth forecast for 2026-2028?

(NASDAQ: ANIP) Ani Pharmaceuticals's forecast annual earnings growth rate of 50.56% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 13.49%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.44%.

Ani Pharmaceuticals's earnings in 2026 is $77,180,000.On average, 10 Wall Street analysts forecast ANIP's earnings for 2026 to be $203,930,416, with the lowest ANIP earnings forecast at $167,021,162, and the highest ANIP earnings forecast at $228,988,076. On average, 8 Wall Street analysts forecast ANIP's earnings for 2027 to be $242,687,489, with the lowest ANIP earnings forecast at $203,941,629, and the highest ANIP earnings forecast at $285,615,605.

In 2028, ANIP is forecast to generate $264,074,181 in earnings, with the lowest earnings forecast at $223,061,157 and the highest earnings forecast at $295,505,016.

What is ANIP's revenue growth forecast for 2026-2028?

(NASDAQ: ANIP) Ani Pharmaceuticals's forecast annual revenue growth rate of 14.18% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.99%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.44%.

Ani Pharmaceuticals's revenue in 2026 is $883,366,000.On average, 9 Wall Street analysts forecast ANIP's revenue for 2026 to be $23,748,041,112, with the lowest ANIP revenue forecast at $20,427,127,601, and the highest ANIP revenue forecast at $25,923,263,008. On average, 7 Wall Street analysts forecast ANIP's revenue for 2027 to be $27,493,010,768, with the lowest ANIP revenue forecast at $25,048,689,256, and the highest ANIP revenue forecast at $29,645,807,696.

In 2028, ANIP is forecast to generate $29,062,758,528 in revenue, with the lowest revenue forecast at $26,237,212,560 and the highest revenue forecast at $31,372,530,232.

What is ANIP's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ANIP) forecast ROA is 20.15%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 19.31%.

What is ANIP's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ANIP price target, the average ANIP price target is $110.00, with the highest ANIP stock price forecast at $124.00 and the lowest ANIP stock price forecast at $90.00.

On average, Wall Street analysts predict that Ani Pharmaceuticals's share price could reach $110.00 by Jan 16, 2027. The average Ani Pharmaceuticals stock price prediction forecasts a potential upside of 48.57% from the current ANIP share price of $74.04.

What is ANIP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ANIP) Ani Pharmaceuticals's current Earnings Per Share (EPS) is $3.50. On average, analysts forecast that ANIP's EPS will be $9.09 for 2026, with the lowest EPS forecast at $7.45, and the highest EPS forecast at $10.21. On average, analysts forecast that ANIP's EPS will be $10.82 for 2027, with the lowest EPS forecast at $9.09, and the highest EPS forecast at $12.74. In 2028, ANIP's EPS is forecast to hit $11.78 (min: $9.95, max: $13.18).

What is ANIP's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ANIP) forecast ROE is 53.67%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.